Table 2.

10-year DR risk for patient groups as categorized by OMclin1, OMclin2, and RS.

OMclin1OMclin2RS
LowHighLowHighLow (<18)Intermediate (18–31)High (>31)Non-low (≥18)Tx low (<11)Tx intermediate (11–25)Tx high (>25)
All patients
Patients, n21942730534138917780257188325133
10-year DR risk (95% CI)4.0% (2.0–7.9)21.2% (17.3–25.7)5.4% (3.3–8.8)24.3% (19.8–29.7)9.9% (7.1–13.7)21.5% (15.9–28.6)27.7% (18.7–39.8)23.4% (18.4–29.4)12.1% (8.0–18.1)12.9% (9.5–17.5)25.5% (18.6–34.3)
HR (95% CI)reference5.81 (2.81–12.01)reference4.93 (2.83–8.60)reference2.55 (1.58–4.10)3.64 (2.09–6.34)2.86 (1.85–4.40)reference1.08 (0.63–1.86)2.57 (1.46–4.50)
Node-negative patients
Patients, n1902922672152961285818614524097
10-year DR risk (95% CI)2.9% (1.2–6.8)17.3% (13.2–22.6)4.9% (2.8–8.5)19.9% (14.8–26.4)6.6% (4.1–10.5)17.3% (11.5–25.6)24.6% (15.0–38.8)19.6% (14.3–26.5)9.3% (5.4–15.8)8.2% (5.1–13.0)23.5% (15.9–33.8)
HR (95% CI)reference6.47 (2.57–16.29)reference4.31 (2.25–8.25)reference2.96 (1.55–5.66)4.73 (2.30–9.76)3.47 (1.93–6.24)reference0.84 (0.40–1.76)3.04 (1.49–6.18)
Node-positive patients
Patients, n291353812693492271438536
10-year DR risk (95% CI)11.8% (3.9–32.6)30.0% (22.4–39.4)8.7% (2.9–24.7)32.4% (24.3–42.3)21.3% (13.5–32.6)31.9% (20.6–47.3)36.5% (19.0–62.4)33.3% (23.3–46.1)22.4% (11.7–40.2)26.9% (18.1–38.8)31.3% (18.1–50.6)
HR (95% CI)reference2.91 (0.89–9.46)reference4.17 (1.28–13.57)reference1.93 (0.95–3.90)2.37 (0.97–5.78)2.05 (1.07–3.90)reference1.35 (0.60–3.08)1.74 (0.69–4.41)